Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 14.5T | 13.7T | 13.6T | 13.7T |
| Cost of revenue | 2.8T | 2.7T | 2.9T | 2.6T |
| Gross profit | 11.7T | 11.0T | 10.7T | 11.2T |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 1.6T | 1.4T | 1.3T | 1.7T |
| Other operating expenses | — | — | — | — |
| Operating income | 9.7T | 9.2T | 9.0T | 9.1T |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 55.8B | 225.9B | 260.2B | 251.6B |
| Other income expense | -600.4B | -1.2T | 148.7B | 270.2B |
| Pretax income | 9.1T | 7.8T | 8.9T | 9.1T |
| Tax provision | 1.5T | 1.2T | 1.5T | 1.5T |
| Net income | 7.5T | 6.5T | 7.3T | 7.6T |
| Basic EPS | 2.7 | 2.3 | 2.6 | 2.7 |
| Diluted EPS | 2.7 | 2.3 | 2.6 | 2.7 |
| Basic average shares | 2.4T | 2.5T | 2.5T | 2.4T |
| Diluted average shares | 2.8T | 2.8T | 2.8T | 2.9T |
| EBITDA | 10.2T | 9.6T | 9.4T | 9.5T |
| Net income from continuing op. | 7.5T | 6.5T | 7.3T | 7.6T |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |